Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL)

100 mL Flexible Ready-to-Administer PAB® IV Container

Levetiracetam in Sodium Chloride Injection is an antiepileptic drug available as a clear, colorless, sterile solution for intravenous administration. It is available in three 100 mL fill single-dose strengths, each containing a different total dose of Levetiracetam.

  • Packaging color differentiated for each strength in stackable individual unit cartons. 
  • Manufactured in B. Braun Medical, Irvine, California
  • PAB IV Containers not made with natural rubber latex, PVC or DEHP

Specific Gravity: 1.008

Contraindication

Known hypersensitivity to levetiracetam; angioedema and anaphylaxis have occurred.

Indication

Levetiracetam in Sodium Chloride Injection is indicated for adjunct therapy in adults (greater than or equal to 16 years of age) with the following seizure types when oral administration is temporarily not feasible:

  • Partial-onset seizures
  • Myoclonic seizures in patients with juvenile myoclonic epilepsy
  • Primary generalized tonic-clonic seizures

Contact a Representative

Please take a minute to complete the request form or call 1-800-227-2862 to contact a B. Braun representative. Thank you.

more

Specifications

Product Identification
Product Code DL5009
NDC Number 00264-5009-90
Reference Number DL5009
Storage and Shipping
Total Shelf Life (Months) 018
Ordering Unit Case
Units per Case 24
Dimensions per Case 16.125 x 8.937 x 5.125 inches
Shipping Weight per Case 8.501 lb